Literature DB >> 30449988

Cardiac Catheterization in the Early Post-Operative Period after Congenital Heart Surgery.

Taner Kasar1, Ibrahim Cansaran Tanidir1, Erkut Ozturk1,2, Candas Kafali1, Murat Sahin1, Okan Yildiz3, Sertac Haydin3, Alper Guzeltas1.   

Abstract

BACKGROUND: The number of diagnostic and interventional cardiac catheterization procedures are increasing in the post-operative period of congenital heart diseases (CHD). The aim of this study was to evaluate data of patients who underwent cardiac catheterization in the early post-operative period after congenital heart surgery (CHS).
METHODS: We retrospectively evaluated the data of patients who underwent cardiac catheterization within 30 days after CHS.
RESULTS: Between 2010 and 2016 in our hospital, 2584 children had operations, and 2911 children underwent cardiac catheterization due to CHD. Cardiac catheterization was performed in 50 (1.9% of the surgeries) of these patients during the early post-operative period. Twenty-nine (58%) of the patients were males. The median age was 7.5 months (range: 15 days-12.5 years), and the median body weight was 6 kg (range: 3-35 kg). Twenty-eight (56%) of the patients had two-ventricle, and 22 (44%) had single ventricle physiology. The median RACHS-1 score was 3 (range: 1-6). Cardiac catheterization was performed under extracorporeal membrane oxygenation (ECMO) support in 16 of the patients. Twenty-four (48%) patients underwent diagnostic catheterization, while 26 (52%) had interventional procedures. Fifteen (30%) patients had a reoperation due to anatomic problems identified during catheterization. Major complications developed in 4 (8%) patients. There was no cases of procedural mortality due to catheterization.
CONCLUSIONS: Cardiac catheterization should be performed in post-operative cardiac patients without hesitation, even under ECMO, if significant hemodynamic or clinical problems cannot be identified clearly by other non- interventional diagnostic techniques.

Entities:  

Keywords:  Cardiac catheterization; Cardiac surgery; Children; Congenital heart defect; Post-operative period

Year:  2018        PMID: 30449988      PMCID: PMC6236567          DOI: 10.6515/ACS.201811_34(6).20180524B

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  17 in total

1.  The Aristotle score: a complexity-adjusted method to evaluate surgical results.

Authors:  F Lacour-Gayet; D Clarke; J Jacobs; J Comas; S Daebritz; W Daenen; W Gaynor; L Hamilton; M Jacobs; B Maruszsewski; M Pozzi; T Spray; G Stellin; C Tchervenkov; C Mavroudis And
Journal:  Eur J Cardiothorac Surg       Date:  2004-06       Impact factor: 4.191

2.  Outcomes following cardiac catheterization after congenital heart surgery.

Authors:  Stephanie L Siehr; Mary Hunt Martin; David Axelrod; Bradley Efron; Lynn Peng; Stephen J Roth; Stanton Perry; Andrew Y Shin
Journal:  Catheter Cardiovasc Interv       Date:  2014-06-17       Impact factor: 2.692

3.  Adverse event rates in congenital cardiac catheterization - a multi-center experience.

Authors:  Lisa Bergersen; Audrey Marshall; Kimberlee Gauvreau; Robert Beekman; Russel Hirsch; Susan Foerster; David Balzer; Julie Vincent; William Hellenbrand; Ralf Holzer; John Cheatham; John Moore; James Lock; Kathy Jenkins
Journal:  Catheter Cardiovasc Interv       Date:  2010-02-15       Impact factor: 2.692

4.  Cardiac catheter procedures during extracorporeal life support: a risk-benefit analysis.

Authors:  Biswa R Panda; Nelson Alphonso; Maheshkumar Govindasamy; Benjamin Anderson; Christian Stocker; Tom R Karl
Journal:  World J Pediatr Congenit Heart Surg       Date:  2014-01-01

Review 5.  Consensus-based method for risk adjustment for surgery for congenital heart disease.

Authors:  Kathy J Jenkins; Kimberlee Gauvreau; Jane W Newburger; Thomas L Spray; James H Moller; Lisa I Iezzoni
Journal:  J Thorac Cardiovasc Surg       Date:  2002-01       Impact factor: 5.209

6.  Cardiac catheterization in the early post-operative period after congenital cardiac surgery.

Authors:  George T Nicholson; Dennis W Kim; Robert N Vincent; Brian E Kogon; Bruce E Miller; Christopher J Petit
Journal:  JACC Cardiovasc Interv       Date:  2014-12       Impact factor: 11.195

7.  Fontan Operation in a Patient with Severe Hypoplastic Right Pulmonary Artery, Single Ventricle, and Heterotaxy Syndrome.

Authors:  Jun-Yen Pan; Chu-Chuan Lin; Jen-Ping Chang
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

8.  Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival.

Authors:  Boban P Abraham; Erikka Gilliam; Dennis W Kim; Michael J Wolf; Robert N Vincent; Christopher J Petit
Journal:  Catheter Cardiovasc Interv       Date:  2016-04-01       Impact factor: 2.692

9.  Interventional catheterization performed in the early postoperative period after congenital heart surgery in children.

Authors:  Evan M Zahn; Nancy C Dobrolet; David G Nykanen; Jorge Ojito; Robert L Hannan; Redmond P Burke
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

10.  Cardiac catheterization procedures in pediatric patients undergoing extracorporeal membrane oxygenation cardiac catheterization, ECMO.

Authors:  Alper Güzeltaş; Taner Kasar; İbrahim Cansaran Tanıdır; Erkut Öztürk; Okan Yıldız; Sertaç Haydin
Journal:  Anatol J Cardiol       Date:  2017-12       Impact factor: 1.596

View more
  2 in total

1.  Assessment of Tricuspid Valve Detachment Efficiency for Ventricular Septal Defect Closure: A Retrospective Comparative Study.

Authors:  Çağatay Bilen; Gökmen Akkaya; Osman Nuri Tuncer; Yüksel Atay
Journal:  Acta Cardiol Sin       Date:  2020-07       Impact factor: 2.672

2.  Left Ventricle Decompression Strategies in Pediatric Peripheral Extracorporeal Membrane Oxygenation.

Authors:  Ying-Jui Lin; Hsi-Yun Liu; Hsuan-Chang Kuo; Chien-Fu Huang; Mei-Hsin Hsu; Ming-Chou Cheng; Shao-Ju Chien; I-Chun Lin; Mao-Hung Lo; Jiunn-Jye Sheu
Journal:  Acta Cardiol Sin       Date:  2019-05       Impact factor: 2.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.